AIRS Medical
Venture Round in 2025
AIRS Medical Co., Ltd. is a healthcare technology company based in Seoul, South Korea, specializing in the development and marketing of artificial intelligence-based software for magnetic resonance imaging (MRI). The company's flagship product, SwiftMR, is an AI-powered MRI reconstruction platform that enhances the quality of MR images acquired under various conditions, leading to improved data accuracy and a better patient experience. AIRS Medical's software suggests optimal parameters for medical image scanning and reconstructs images while minimizing artifacts. Additionally, it provides image quality assessment tools that visualize unseen artifacts and enhance image quality affected by motion, metal, and hardware imperfections. Through its innovative solutions, AIRS Medical aims to accelerate MRI scans and increase productivity for medical professionals.
AIRS is at the forefront of advancing orthopedic surgery, setting the stage for the future with its innovative surgical platforms. The company is preparing for the next era in surgical technology, known as SURGERY 4.0. By leading the way with cutting-edge solutions, AIRS aims to transform orthopedic procedures, enhance precision, and redefine standards in surgical care.
Soomvi
Venture Round in 2024
Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving system services. It develops advanced drones that are engineered to enhance safety and performance through the integration of sophisticated technology. These drones feature a sensor-isolated and vibration-resistant structural design, enabling reliable operation in demanding environments. They are equipped with capabilities for real-time synchronization and communication of flight information, along with a backup control system for added safety. Soomvi's innovations aim to meet the needs of various industrial applications, enhancing operational efficiency while ensuring security.
ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.
Panmnesia
Series A in 2024
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.
Novelty Nobility
Series C in 2024
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.
EMCRAFTS
Convertible Note in 2024
EMCRAFTS specializes in the manufacturing and designing of scanning electron microscopes.
LINER is an innovative company that has developed Asia's first AI Agent, known as the "AI Workspace." This autonomous agent utilizes LLM-based artificial intelligence to perform a variety of complex tasks, significantly enhancing user productivity. LINER's personalized search engine, powered by advanced technologies like GPT-4, allows users to efficiently collect, manage, and derive insights from information, drastically reducing research time from hundreds of minutes to mere seconds. With a user base exceeding 94% from outside Korea and spanning over 100 countries, LINER stands out for its unique highlighter database, which differentiates its offerings in the competitive landscape of productivity tools.
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.
MedInTech
Series B in 2024
MedInTech is a company that specializes in the development of advanced medical devices for endoscopy, specifically focusing on the digestive system. Its innovative product features a motorized endoscope that offers an intuitive and user-friendly control mechanism, which is designed to enhance the efficiency and effectiveness of surgical procedures. The device is equipped with a lightweight and comfortable handle, facilitating ease of use for surgeons. It incorporates artificial intelligence to assist in lesion detection and classification, thereby reducing the risk of misdiagnosis and improving patient safety. Through its technology, MedInTech aims to advance the field of endoscopic surgery by providing tools that enhance both precision and reliability in medical diagnostics.
Creative MUT
Series A in 2024
Creative MUT is a media solutions company that specializes in content planning, production, BX, and VFX creations.
Edgecare is a manufacturing company that specializes in developing medical devices. These include precision and optical devices designed to enhance healthcare quality and affordability. The company's portfolio includes bladder image scanners for urinary diagnosis, enabling early disease detection and treatment.
Mardi Mercredi
Series A in 2023
Mardi Mercredi is a clothing retailer specializing in easy-to-wear everyday apparel for women, men, and children. The company offers a diverse range of products, including jackets, jeans, tops, shirts, and various accessories. Known for its French-inspired designs, Mardi Mercredi caters to the fashion needs of its customers by providing stylish and practical clothing options that reflect current trends while ensuring comfort and accessibility.
Panmnesia
Seed Round in 2023
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.
AB180 is a performance marketing firm that specializes in data-driven solutions to enhance business outcomes in the digital landscape. The company has developed a platform that leverages data analytics and marketing technology to help organizations gain insights into customer behavior. By collecting and processing real-time behavioral data from mobile users, AB180 enables businesses to better understand their customers and optimize their marketing strategies. This approach allows organizations to improve their marketing results and adapt effectively to the evolving digital market.
Solvook is a copyright licensing platform that specializes in providing copyright clearance services for educational materials. The company operates a cloud-based library that offers a diverse range of digital educational resources, allowing users to conveniently access a comprehensive database of knowledge. By streamlining the licensing process, Solvook aims to facilitate the use of copyrighted materials in an educational context, supporting both educators and learners in their pursuit of knowledge.
Best Graphene
Series A in 2023
Best Graphene specializes in the manufacturing of graphene products tailored for a wide range of industrial sectors. Best Graphene provides a diverse array of products to cater to various needs, such as graphene colloid, graphene ink and paste, additive graphene, and customizable graphene solutions. These offerings ensure optimal process suitability and compatibility across different materials, empowering users to harness the unique properties of graphene for enhanced performance and applications in their respective industries.
NextQure
Seed Round in 2023
NextQure is an electronic medicine company focused on advancing the transcranial magnetic stimulation (TMS) market and promoting home-based treatment solutions. The company offers a range of products designed to enhance patient care, including emqure, which aims to improve language memory and cognitive function, and emfree, which provides treatment for depression. Additionally, NextQure is developing therapies for intractable diseases, addiction, and sleep disorders, all aimed at facilitating effective treatment in a home environment. Through its innovative approach, NextQure seeks to deliver quality healthcare solutions to patients outside traditional clinical settings.
Youniv
Venture Round in 2023
Youniv is a digital media and content production company based in Korea that focuses on creating video content for university students, particularly those belonging to Generation Z. The platform is designed to serve the specific needs of students by producing relatable and informative content that enhances their knowledge and understanding of various subjects. By prioritizing the interests and perspectives of its audience, Youniv aims to foster a sense of connection and empathy among students, making it a valuable resource for educational and personal growth.
GrowV is an education technology company that develops a learning platform designed to cultivate a love for learning among young students. The platform offers personalized educational content in subjects like English, Mathematics, and Korean, delivered via a dedicated tablet tailored for younger ages. This enables children to engage with learning materials suited to their abilities, fostering growth and achievement of their academic goals.
Onconic Therapeutics
Series B in 2022
Onconic Therapeutics is a biotechnology company dedicated to the research and development of innovative cancer treatments. The company focuses on creating next-generation anti-cancer therapies that target specific mechanisms involved in cancer progression. By simultaneously inhibiting signal delivery agents that promote cancer cell growth and DNA damage repair enzymes, Onconic Therapeutics aims to enhance the effectiveness of its therapies. This approach provides healthcare professionals with advanced options for treating various types of cancer, contributing to the ongoing efforts to improve patient outcomes in oncology.
People & Technology
Series B in 2022
People & Technology is a South Korean company specializing in digital transformation-based artificial intelligence solutions focused on indoor geolocation and smart sensing. Established in 2013, it offers a comprehensive platform that includes IoT, Location Based Systems, and Real Time Location Systems. The company serves a diverse range of sectors, including healthcare, manufacturing, defense, smart cities, and public services, providing solutions that enhance employee safety, asset tracking, security, access control, flow management, and overall process efficiency. With over 100 corporate clients, People & Technology has established itself as a prominent provider in South Korea and is actively expanding its presence internationally. The company is recognized for helping clients improve productivity and reduce corporate risks while optimizing procurement processes.
Aurumplanet
Series B in 2022
Aurumplanet (아우름플래닛) is a Korean online platform that provides IT-related information. It was launched in September 2012 in Seoul, Korea.
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.
LINER is an innovative company that has developed Asia's first AI Agent, known as the "AI Workspace." This autonomous agent utilizes LLM-based artificial intelligence to perform a variety of complex tasks, significantly enhancing user productivity. LINER's personalized search engine, powered by advanced technologies like GPT-4, allows users to efficiently collect, manage, and derive insights from information, drastically reducing research time from hundreds of minutes to mere seconds. With a user base exceeding 94% from outside Korea and spanning over 100 countries, LINER stands out for its unique highlighter database, which differentiates its offerings in the competitive landscape of productivity tools.
Novelty Nobility
Series B in 2022
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.
Zenerate
Seed Round in 2022
Zenerate Inc. is a South Korean company founded in 2020 that specializes in providing innovative building design solutions utilizing artificial intelligence. The firm’s AI platform evaluates various factors, including construction costs, rental prices, and project objectives, to generate optimized building designs. By automating manual processes, Zenerate's technology enables architects, urban planners, and designers to efficiently explore a wide range of design alternatives, thereby enhancing productivity and decision-making in real estate development. Through its focus on AI-powered feasibility solutions, Zenerate aims to revolutionize the approach to spatial and structural development in the industry.
D'CENT is a company specializing in cryptocurrency hardware wallets designed to securely store crypto assets. The firm offers embedded security services, including digital asset cold storage, secure private key storage, and transaction execution. D'CENT provides a combination of software and hardware security solutions for customers holding digital assets, ensuring reliable and trustworthy connectivity for their clients.
Greenergy
Series A in 2021
Greenergy designs and manufactures lithium-ion rechargeable batteries through Greenergy's technology.
UrbanPlay
Series A in 2021
UrbanPlay Inc. is a South Korean company, established in 2013 and headquartered in Seoul, that specializes in creating urban culture content. The company focuses on addressing urban issues through accessible technology and innovative solutions. UrbanPlay collects and processes both tangible and intangible content in the region, offering a variety of services that include online platforms, regional projects, multimedia publications, and space utilization. Its community-oriented platform provides real estate content services, local marketing, and merchandise, all designed to foster a sustainable urban cultural ecosystem. Through its initiatives, UrbanPlay enables users to engage with and reflect on urban lifestyles in a meaningful way.
N.thing, Inc. is a South Korean Agri-Food technology company established in January 2014, focused on revolutionizing the agricultural sector through innovative IoT solutions. The company has developed the CUBE, a modular vertical farming system that enhances productivity and efficiency by providing an optimized environment for various crops using a dedicated operating system. In addition to the CUBE, N.thing offers SQUARE, a modular hydroponic kit that enables users to grow greens and herbs collaboratively, and Planty, the first internet-connected social pot that allows for real-time monitoring of plant conditions. N.thing also provides Life, a smart gardening journal for plant enthusiasts to document and share their gardening experiences. The company has received accolades for its design and technological excellence, including the iF Design Award and the Best of Innovation award at CES 2020. With plans for large-scale expansion following successful proof of concept trials in the UAE, N.thing aims to connect individuals with nature and enhance the farm-to-table experience through its innovative agricultural solutions.
Neurive
Seed Round in 2021
Neurive is a medical research and development company focused on creating electronic and digital medicines. It specializes in developing digital therapeutics and wearable devices resembling mobile phones, along with non-invasive vagus nerve stimulation technologies. Neurive's innovations aim to provide effective healthcare treatments for conditions like degenerative brain diseases, cognitive dysfunction, depression, and tinnitus, thereby enabling improved patient outcomes.
SeaWith is a biotechnology startup focused on creating cell-cultured steak derived from seaweed, specifically utilizing a low-iodine seaweed variant known as Yo.od. The company aims to provide a sustainable alternative to traditional meat production by developing clean meat in a laboratory setting. SeaWith employs its proprietary culture media, made from microalgae, to cultivate meat that retains the taste and texture of conventional meat while being more affordable due to the abundance of microalgae. By doing so, SeaWith addresses the ethical and environmental challenges associated with livestock farming, offering consumers a delicious and cost-effective protein source that aligns with growing demands for sustainable food options.
SIR.LOIN is an e-commerce platform specializing in the sale of high-quality Korean beef. The company oversees the entire supply chain, encompassing feeding, breeding, aging, and processing of the meat. This comprehensive approach ensures that customers receive premium meat products directly, eliminating common barriers associated with purchasing quality meat. By focusing on quality and efficiency, SIR.LOIN aims to provide a seamless shopping experience for consumers seeking authentic Korean beef.
WHYNOT Media
Series C in 2021
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and offering a diverse range of entertainment content, including web series, short films, and web dramas. Notable titles produced by WHYNOT Media include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." The company excels in creating content that resonates with various cultural backgrounds, often through branded content and transmedia storytelling. By emphasizing short-form drama and versatile content franchises, WHYNOT Media aims to provide easily accessible entertainment for its audience.
Cenyx Biotech
Series A in 2021
Cenyx Biotech is a pioneering company in the field of nanobiotechnology, focused on developing innovative diagnostic and therapeutic nano-compounds utilizing nanozymes and nanoparticles. The company aims to transform healthcare by creating a nano-biotech agent capable of simultaneously eliminating superoxide, hydrogen peroxide, and hydroxyl radicals. This technology is particularly relevant for addressing excessive inflammatory responses that arise during the early stages of subarachnoid hemorrhage. By leveraging these advanced nano-compounds, Cenyx Biotech seeks to provide effective solutions for patients and healthcare practitioners, ultimately enhancing treatment outcomes in critical medical conditions.
HOWSER provides furniture construction and delivery solutions through an online infrastructure based on IT technology.
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.
MitoImmune Therapeutics
Series B in 2021
MitoImmune Therapeutics is a biotechnology company focused on drug research and development aimed at treating mitochondrial dysfunction and various cellular disorders. The company specializes in creating therapies for diseases related to mitochondrial dysfunction, including necrotic and inflammatory conditions. By developing targeted treatments, MitoImmune Therapeutics aims to enhance the quality of life for patients suffering from these complex health issues.
Biobab AiBIO
Series A in 2021
Biobab AiBIO is a biotechnology company focused on drug development through the application of artificial intelligence. The company specializes in bio-space voyager technology, which enhances the efficiency of drug discovery, particularly for patients suffering from intractable and rare diseases. By leveraging cryogenic electron microscopy (cryo-EM), Biobab AiBIO addresses the limitations of traditional X-ray crystallography, allowing for detailed analysis of the three-dimensional structures of novel target proteins. This advanced approach enables the identification and development of new drugs aimed at innovative therapeutic targets, positioning Biobab AiBIO at the forefront of biopharmaceutical advancements.
everyone's kitchen
Series A in 2021
everyone's kitchen helps in lowering the high cost burden for starting a business.
ImmunoMet Therapeutics
Venture Round in 2021
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, dedicated to developing and commercializing innovative oncology drugs. Founded in 2015, the company focuses on improving the quality of life for cancer patients through its advanced pipeline of products. This includes metabolic regulators designed to target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors aimed at anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet Therapeutics is positioned to make significant contributions to the field of oncology.
B:eat Corp
Series A in 2021
B: eat is a retail automation platform intended to run a robot-based cafe.
Agreable is a brand commerce startup that manufactures and distributes lifestyle products.
Lab n People
Series B in 2020
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.
Aurumplanet
Series A in 2020
Aurumplanet (아우름플래닛) is a Korean online platform that provides IT-related information. It was launched in September 2012 in Seoul, Korea.
LINER is an innovative company that has developed Asia's first AI Agent, known as the "AI Workspace." This autonomous agent utilizes LLM-based artificial intelligence to perform a variety of complex tasks, significantly enhancing user productivity. LINER's personalized search engine, powered by advanced technologies like GPT-4, allows users to efficiently collect, manage, and derive insights from information, drastically reducing research time from hundreds of minutes to mere seconds. With a user base exceeding 94% from outside Korea and spanning over 100 countries, LINER stands out for its unique highlighter database, which differentiates its offerings in the competitive landscape of productivity tools.
SN BioScience
Series B in 2020
SN BioScience specializes in nano-formulation screening services aimed at enhancing the delivery of small molecules, oligonucleotides, peptides, and proteins. Utilizing its proprietary double core-shell technology, the company focuses on developing innovative drug delivery systems, particularly for cancer therapeutics. By employing a diverse range of lipids and polymers, SN BioScience addresses challenges related to solubility and delivery of poorly soluble drugs, enabling clients to create stable nano-sized micelles, nanoparticles, or liposomes. This approach not only fosters research advancement but also opens significant opportunities for the development of novel oncology products.
INITECH
Seed Round in 2019
INITECH, established in 1997 and headquartered in Seoul, South Korea, is a leading IT security and financial services company. It specializes in developing and implementing robust e-banking systems, including service planning, development, and maintenance, as well as internet and smart banking solutions. INITECH operates data centers offering supplementary services for enterprises and provides a range of IT professional services, such as security system management, consulting, and training programs. The company's portfolio also includes security solutions like PKI, biometrics, ISoT, and IAM, along with system and DB security, endpoint security, and hardware security modules. INITECH is a subsidiary of H&C Network Co. Ltd.
UrbanPlay
Series A in 2019
UrbanPlay Inc. is a South Korean company, established in 2013 and headquartered in Seoul, that specializes in creating urban culture content. The company focuses on addressing urban issues through accessible technology and innovative solutions. UrbanPlay collects and processes both tangible and intangible content in the region, offering a variety of services that include online platforms, regional projects, multimedia publications, and space utilization. Its community-oriented platform provides real estate content services, local marketing, and merchandise, all designed to foster a sustainable urban cultural ecosystem. Through its initiatives, UrbanPlay enables users to engage with and reflect on urban lifestyles in a meaningful way.
WHYNOT Media
Series B in 2019
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and offering a diverse range of entertainment content, including web series, short films, and web dramas. Notable titles produced by WHYNOT Media include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." The company excels in creating content that resonates with various cultural backgrounds, often through branded content and transmedia storytelling. By emphasizing short-form drama and versatile content franchises, WHYNOT Media aims to provide easily accessible entertainment for its audience.
Lab n People
Seed Round in 2019
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.
MitoImmune Therapeutics
Series A in 2019
MitoImmune Therapeutics is a biotechnology company focused on drug research and development aimed at treating mitochondrial dysfunction and various cellular disorders. The company specializes in creating therapies for diseases related to mitochondrial dysfunction, including necrotic and inflammatory conditions. By developing targeted treatments, MitoImmune Therapeutics aims to enhance the quality of life for patients suffering from these complex health issues.
SOS Lab is a specialized company that develops and manufactures LiDAR technology, which utilizes lasers to measure distances and shapes of surrounding environments. The company focuses on creating innovative solutions for self-driving cars, highlighted by its hybrid LiDAR system, the SL-1. This long-range system combines traditional motor scanning with a solid-state MEMS mirror, offering a more affordable option compared to existing products in the market. In addition to the SL-1, SOS Lab provides two other LiDAR products, the GL-3 for factory automation and robotics, and the TL-3 for security and automatic doors. The company aims to enhance its offerings by integrating hardware-based sensors with AI-driven object recognition and tracking technologies, using 3D point cloud data. SOS Lab collaborates with automotive electronics partners and global semiconductor firms to advance its next-generation Solid-State LiDAR. With research and development centers in Seoul and Gwangju, alongside business operations in Silicon Valley, SOS Lab seeks to expand its global presence and contribute to the self-driving and advanced driver-assistance systems (ADAS) markets.
Fresh Easy
Series A in 2018
Fresh Easy is a distributor of meal kits.
JLK, Inc. is a South Korean company specializing in artificial intelligence-driven medical and security solutions. It develops advanced AI platforms that support diagnosis and treatment by providing real-time, on-site services integrated with hospital systems. JLK focuses on a range of medical conditions, offering solutions for brain diseases such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease, as well as lung diseases, coronary artery disease, and prostate cancer. The company also emphasizes digital pathology and data analysis in its offerings. Formerly known as JLK INSPECTION Co., Ltd., JLK, Inc. is headquartered in Cheongju, South Korea.
Caret Games
Venture Round in 2018
Caret Games is a company specialized in developing mobile games with over 50 employees based on South Korea. The company consists of talented developers and they are developing games with passion. Caret Games developed Full3D mobile MMORPG ‘RebirthM’ in the end of 2017. The company is trying to make a game which many people can enjoy and play for a long time, and the first is ‘RebirthM’. Caret Games services 'RebirthM' directly in South Korea and is currently preparing for global service. About "Rebirth M"! The game also known as Rebirth: Shadow of Salvation, is a mobile MMORPG that’s supposed to rival PC MMORPGs. Made with Unity3D, the game boasts high graphics and PC-like gameplay experience. Now that it’s been more than a year since its announcement in South Korea, the game is finally out in Brazil which a global release will follow suit later.
Urbanbase
Series A in 2017
Urbanbase Inc. is a South Korean company founded in 2014 that specializes in a design platform transforming two-dimensional floor plans into three-dimensional models. The company offers patented technology that allows for the rapid creation of 3D, augmented reality (AR), and virtual reality (VR) representations of interior spaces. Urbanbase provides a B2C VR home furnishing platform and an AR mobile application aimed at enhancing the interior design experience. Additionally, the company delivers B2B solutions, including internally developed 3D, AR, and VR APIs tailored for various industries such as real estate, home design, and retail. Urbanbase's clientele includes notable companies like LG, iLoom, and Daelim, along with over 40 other interior and furniture businesses.
Wantedlab
Series B in 2017
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer job applicants to companies and earn rewards when those applicants are hired. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, all of which utilize Wanted to identify and recruit top talent in Asia. Since its inception, Wantedlab has raised over $20 million in funding and is actively expanding its presence to major cities worldwide.
ImmunoMet Therapeutics
Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, dedicated to developing and commercializing innovative oncology drugs. Founded in 2015, the company focuses on improving the quality of life for cancer patients through its advanced pipeline of products. This includes metabolic regulators designed to target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors aimed at anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet Therapeutics is positioned to make significant contributions to the field of oncology.
Yanolja is a leisure platform headquartered in Seoul, South Korea, that provides a comprehensive range of online accommodation and travel services. Founded in 2005, the company connects various aspects of travel, including lodging, leisure activities, and transportation, allowing users to book diverse hotel options globally. Yanolja leverages advanced technologies such as artificial intelligence, blockchain, and IoT to enhance its offerings. In addition to consumer services, the company provides cloud-based software solutions for hotels, residences, and leisure facilities, streamlining operations and improving efficiency across the travel industry.
InnoSpark
Series B in 2015
InnoSpark Inc. is a mobile game development company based in Seoul, South Korea, founded in 2012. The company focuses on creating traffic-oriented network games that emphasize social interaction. Its portfolio includes combat strategy games and social dragon breeding games, aiming to engage users through innovative gameplay experiences. InnoSpark is dedicated to developing and publishing games that appeal to a global audience.
The News Funnel
Angel Round in 2014
The News Funnel is an online platform designed to aggregate real estate news and public relations content, catering specifically to busy professionals in the industry. By leveraging a sophisticated search engine, the company curates and distributes trade news and insights from reputable media sources and real estate firms. Users can customize their news feeds according to geographic markets, industry segments, and personal interests, ensuring they stay informed about relevant developments. Additionally, The News Funnel allows clients to upload their own company news at no cost, enhancing the platform's utility for real estate professionals seeking to engage with current trends and updates in the market.
ChannelBreeze
Venture Round in 2013
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.
ZigBang
Seed Round in 2011
ZigBang Co., Ltd. is a property listing platform and application based in Seoul, South Korea, which connects real estate agents with renters. Founded in 2010, the company operates a real estate marketplace that facilitates apartment hunting through its mobile and web platforms. Users can search for rental properties based on various criteria, including the number of rooms, occupants, and price. ZigBang has reported a user base of approximately 6 million, providing a comprehensive tool for individuals seeking rental accommodations while aiming to optimize their search and potentially reduce housing costs.